Psychiatry and Neurology, Neurology · New York, NY
NPI
1811280951
Since 2011
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1305 York Ave
New York, NY, 10021
Phone (646) 962-9800
Groups this clinician bills Medicare through
Medicare paid, 2024
$36K
1,170 services
Medicare patients, 2024
130
Average age 71
Drug cost, 2024
$2.5M
1,731 prescriptions
Company payments, 2025
$1,376
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ulrike W Kaunzner was code 99214 (office e&m - established), 85 times for 58 patients. In total Ulrike W Kaunzner billed 1,170 services in 20 codes, and Medicare paid $36K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-01-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 85 | 58 | $107.44 | $9,132 |
| 99215 Office E&M - Established | Office | 54 | 36 | $157.44 | $8,502 |
| 99205 Office E&M - New | Office | 11 | 11 | $174.09 | $1,915 |
By year: 2022 $38K for 1,225 services; 2023 $63K for 2,592 services; 2024 $36K for 1,170 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 28 | 21 | $8.40 | $235 |
Medicare prescription drug claims, 2024
In 2024, the drug Ulrike W Kaunzner prescribed most often to Medicare patients was Gabapentin, with 155 prescriptions and refills. In total Ulrike W Kaunzner wrote 1,731 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 155 | 261 | 43 | $3,528 |
| Baclofen Generic | 102 | 148 | 22 | $2,035 |
| Dalfampridine Er Dalfampridine | 67 | 74 | 11 | $20K |
| Pregabalin Generic | 60 | 70 | 18 | $1,227 |
| Diazepam Generic | 57 | 57 | 14 | $4,239 |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 46 | 46 | Under 11 | $230K |
| Duloxetine Hcl Generic | 40 | 65 | Under 11 | $550 |
| Lamotrigine Generic | 36 | 45 | Under 11 | $248 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 32 | 64 | Under 11 | $524 |
| Lacosamide Generic | 31 | 37 | Under 11 | $3,261 |
| Topiramate Generic | 29 | 58 | 11 | $616 |
| Dimethyl Fumarate Generic | 29 | 29 | Under 11 | $67K |
| Nortriptyline Hcl Generic | 27 | 58 | 12 | $426 |
| Amantadine Amantadine Hcl | 27 | 49 | Under 11 | $1,942 |
| Carbamazepine Er Carbamazepine | 27 | 47 | Under 11 | $3,137 |
Brand drugs: 346 claims; generic drugs: 1,365 claims; opioid claims: 32.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ulrike W Kaunzner $1,376 ($1,376 in general payments such as food, travel and fees) from 3 companies. The largest payer was TG Therapeutics, Inc. with $1,350.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.